|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [648]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [648]
haviors of children of well and depressed mothers. Development and Psychopathology, 3, 243–251.
Ryan, C. E. (2002) Clinical and research issues in the evaluation and treatment of families. Medicine and Health, Rhode Island, 85, 278–280.
Ryan, N. D. (2003). Medication treatment for depression in children and adolescents. CNS Spectrums, 8, 283–287.
Ryan, N. D., Meyer, V., Dachille, S., Mazzie, D., & Puig-Antich, J. (1988). Lithium antidepressant augmentation in TCA-refractory depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 371–376.
Ryan, N. D., Puig-Antich, J., Rabinovich, H., Fried, J., Ambrosin, P., Meyer, V., et al. (1988). MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 755–758.
Rynn, M. A., Findling, R., Emslie, G., Marcus, R. N., Fernandes, L. A., D'Amico, M. F., et al. (2002). Efficacy and safety of nefazodone in adolescents with MDD. Poster presented at the 155th annual meeting of the American Psychiatric Association, Philadelphia, PA.
Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002). Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety. American Journal of Psychiatry, 159, 1146–1154.
Schlenger, W. E., Caddell, J. M., Ebert, L., Jordan, B. K., Rourke, K. M., Wilson, D., et al. (2002).
Psychological reactions to terrorist attacks: Findings from the National Study of Americans' Reactions to September 11. Journal of the American Medical Association, 288, 581–588.
Schneider, L. S., Cooper, T. B., Staples, F. R., & Sloane, R. B. (1987). Prediction of individual dosage of nortriptyline in depressed elderly outpatients. Journal of Clinical Psychopharmacology, 7, 311–314.
Schulberg, H. C., Block, M. R., Madonia, M. J., Scott, C. P., Rodriguez, E., Imber, S. D., et al. (1996). Treating major depression in primary care practice. Eight-month clinical outcomes. Archives of General Psychiatry, 53, 913–919.
Schwab, S. G., Hallmayer, J., Lerer B., Albus, M., Bormann, M., Honig, S., et al. (1998). Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. American Journal of Human Genetics, 63, 1139.
Sedlak, A. J., & Broadhurst, D. D. (1996). Executive summary of the Third National Incidence Study of Child Abuse and Neglect. Washington, DC: U.S. Department of Health and Human Services, Administration for Children and Families, Administration on Children, Youth and Families, National Center on Child Abuse and Neglect.
Segal, J., Berk, M., & Brook, S. (1998). Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial. Clinical Neuropharmacology, 21, 176–180.
Seligman, M. E. P. (1975). Helplessness: On depression, development and death. New York: Freeman.
Seth, R., Jennings, A. L., Bindman, J., Phillips, J., & Bergmann, K. (1992). Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. British Journal of Psychiatry, 161, 562–565.
Shapiro, D. A., Barkham, M., Rees, A., Hardy, G. E., Reynolds, S., & Startup, M. (1994) Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy. Journal of Consulting and Clinical Psychology, 62, 522–534.
end p.648
|
|
|
|
